NCT01740570 2018-01-19Phase I/II Cabazitaxel for Recurrent Malignant GliomaM.D. Anderson Cancer CenterPhase 1/2 Withdrawn
NCT01866449 2017-10-26Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma MultiformeUniversity of UlmPhase 2 Completed24 enrolled